Literature DB >> 12721397

Adverse reactions to vaccines.

Bryan L Martin1, Michael R Nelson, Joyce N Hershey, Renata J M Engler.   

Abstract

(The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.) Immunization healthcare is becoming increasingly complex as the number and types of vaccines have continued to expand. Like all prescription drugs, vaccines may be associated with adverse events. The majority of these reactions are self-limited and not associated with prolonged disability. The media, Internet and public advocacy groups have focused on potentially serious vaccine-associated adverse events with questions raised about causal linkages to increasing frequencies of diseases such as autism and asthma. Despite a lack of evidence of a causal relationship to a variety of vaccine safety concerns, including extensive reviews by the Institute of Medicine, questions regarding vaccine safety continue to threaten the success of immunization programs. Risk communication arid individual risk assessment is further challenged by the public health success of vaccine programs creating the perception that certain vaccines are no longer necessary or justified because of the rare reaction risk. There is a need for improved understanding of true vaccine contraindications and precautions as well as host factors and disease threat in order to develop a patient specific balanced risk communication intervention. When they occur, vaccine related adverse events must be treated, documented and reported through the VAERS system. The increasing complexity of vaccination health care has led the Center of Disease Control and Prevention (CDC) to identify Vaccine Safety Assessment and Evaluation as a potential new specialty.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12721397     DOI: 10.1385/CRIAI:24:3:263

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   10.817


  18 in total

1.  Safe MMR vaccination despite neomycin allergy.

Authors:  D Elliman; B Dhanraj
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

2.  IgE-mediated systemic reactions to gelatin included in the varicella vaccine.

Authors:  M Sakaguchi; T Yamanaka; K Ikeda; Y Sano; H Fujita; T Miura; S Inouye
Journal:  J Allergy Clin Immunol       Date:  1997-02       Impact factor: 10.793

3.  Injection granuloma of the buttock.

Authors:  L Michaels; R W Poole
Journal:  Can Med Assoc J       Date:  1970-03-28       Impact factor: 8.262

4.  Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service.

Authors:  M Gold; H Goodwin; S Botham; M Burgess; M Nash; A Kempe
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

5.  Pertussis vaccination and asthma: is there a link?

Authors:  M R Odent; E E Culpin; T Kimmel
Journal:  JAMA       Date:  1994 Aug 24-31       Impact factor: 56.272

6.  Neomycin sensitivity and the MMR vaccine.

Authors:  R L Rietschel; R Bernier
Journal:  JAMA       Date:  1981-02-13       Impact factor: 56.272

7.  Frequency and severity of infections in day care.

Authors:  E R Wald; B Dashefsky; C Byers; N Guerra; F Taylor
Journal:  J Pediatr       Date:  1988-04       Impact factor: 4.406

8.  Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-07-09       Impact factor: 17.586

9.  Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines.

Authors:  M Sakaguchi; T Nakayama; S Inouye
Journal:  J Allergy Clin Immunol       Date:  1996-12       Impact factor: 10.793

Review 10.  An assessment of thimerosal use in childhood vaccines.

Authors:  L K Ball; R Ball; R D Pratt
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

View more
  3 in total

1.  Localized Hypertrichosis at Vaccination Site.

Authors:  Kavita Poonia; Pragati Gogia; Mala Bhalla
Journal:  Int J Trichology       Date:  2018 May-Jun

2.  The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergists.

Authors:  Jason Behrmann
Journal:  Allergy Asthma Clin Immunol       Date:  2010-09-15       Impact factor: 3.406

3.  Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand.

Authors:  Punnee Pitisuttithum; Supachai Rerks-Ngarm; Valai Bussaratid; Jittima Dhitavat; Wirach Maekanantawat; Swangjai Pungpak; Pravan Suntharasamai; Sirivan Vanijanonta; Sorachai Nitayapan; Jaranit Kaewkungwal; Michael Benenson; Patricia Morgan; Robert J O'Connell; Jeffrey Berenberg; Sanjay Gurunathan; Donald P Francis; Robert Paris; Joseph Chiu; Donald Stablein; Nelson L Michael; Jean-Louis Excler; Merlin L Robb; Jerome H Kim
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.